Literature DB >> 16494867

Plasmodium berghei: development of an irreversible experimental malaria model in Wistar rats.

Helen Cristina Pedroni1, Clarissa Cassini Bettoni, Silvia Maria Spalding, Teresa Dalla Costa.   

Abstract

A protocol to infect five-week-old Wistar rats by Plasmodium berghei which resulted in 100% mortality was developed in this work. In order to accomplish this goal, the effect of the administration of 10(7) and 10(8) parasitized erythrocytes by i.v. and i.p. route was investigated. The animals inoculated with 10(7) parasitized red blood cells by i.p. and i.v. routes showed 25 and 50% mortality, respectively. Inoculation with 10(8) parasitized erythrocytes by both routes resulted in a 100% lethal infection. The i.v. inoculation showed less scattered results and it was preferred over the i.p. route. The suitability of the protocol developed was evaluated by treating infected Wistar rats with chloroquine (30 mg/kg/day). A decreased parasitemia after the treatment was observed until the complete eradication of the parasite, around 10 days post-inoculation. Parasitemia depression after chloroquine treatment demonstrates the utility of the model developed to test new antimalarial drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494867     DOI: 10.1016/j.exppara.2005.12.017

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

1.  Evaluation of the malaria elimination policy in Brazil: a systematic review and epidemiological analysis study.

Authors:  J O Melo; M A O Padilha; R T A Barbosa; W J Alonso; A Y Vittor; G Z Laporta
Journal:  Trop Biomed       Date:  2020-06       Impact factor: 0.717

2.  In vivo studies on the biochemical indices of Plasmodium berghei infected mice treated with Alstonia boonei leaf and root extracts.

Authors:  Grace C Onyishi; Godwin C Nwosu; Joseph E Eyo
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

3.  Anti-plasmodial and anti-inflammatory activities of cyclotide-rich extract and fraction of Oldenlandia affinis (R. & S.) D.C. (Rubiaceae).

Authors:  Chukwuemeka Sylvester Nworu; Tochukwu Ifenyinwa Ejikeme; Adaobi Chioma Ezike; Okechukwu Ndu; Theophine Chinwuba Akunne; Collins Azubuike Onyeto; Paul Okpalanduka; Peter Achunike Akah
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.